Home / Recalls / McKesson Corporation dba McKesson Drug Company / D-0851-2022

D-0851-2022 Class II Ongoing

Recalled by McKesson Corporation dba McKesson Drug Company — Memphis, TN

Recall Details

Product Type
Drugs
Report Date
May 11, 2022
Initiation Date
April 21, 2022
Termination Date
N/A
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
5,640 tubes

Product Description

Erythromycin Topical Gel USP, 2%, Net Wt 60 g tube, Rx only, Manufactured by: Teligent Pharma, Inc. Buena, NJ 08310 Distributed by: McKesson Corporation dba Sky Packaging 4971 Southridge Blvd., Suite 101 Memphis, TN 38141, NDC 63739-053-68

Reason for Recall

CGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Teligent Pharma, Inc.is discontinuing its stability study program.

Distribution Pattern

Nationwide in the United States including Guam and the Northern Mariana Islands.

Code Information

Lot: 15723, Exp.: 06/30/2022

Other recalls by McKesson Corporation dba McKesson Drug Company

  • D-0850-2022 Class II — Betamethasone Dipropionate Ointment USP, 0.05%* (Augmented) (Potency expressed a (April 21, 2022)
  • D-0848-2022 Class II — Lidocaine Hydrochloride Topical Solution USP 4% (40 mg/mL), 50 mL bottle, Rx onl (April 21, 2022)
  • D-0849-2022 Class II — Lidocaine Prilocaine Cream USP, 2.5%/2.5% Net Wt. 30 gram tube, Rx Only, Distrib (April 21, 2022)
  • D-0847-2022 Class II — Halobetasol Propionate Ointment 0.05% Net Wt., 50 gram tube, Rx Only, Manufactur (April 21, 2022)
  • D-0630-2021 Class III — Levetiracetam Tablets USP, 250 mg UD 100 Tablets (10x10) boxes, Rx Only, Distrib (May 26, 2021)